AgingAlzheimer's/DementiaPart D/Prescription Drugs

Study: Alzheimer’s drug shows modest success slowing declines in memory, thinking

(By Jon Hamilton for NPR)

An experimental drug that removes a substance called amyloid from the brain appears to slow down Alzheimer’s disease.

The drug, called lecanemab, reduced the rate of cognitive decline by 27% in a study of nearly 1,800 people in the early stages of Alzheimer’s, scientists reported at the Clinical Trials on Alzheimer’s Disease meeting in San Francisco. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or

Leave a Reply